A detailed history of Squarepoint Ops LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 16,629 shares of EWTX stock, worth $531,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,629
Previous 52,541 68.35%
Holding current value
$531,296
Previous $946,000 53.17%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$15.88 - $29.5 $570,282 - $1.06 Million
-35,912 Reduced 68.35%
16,629 $443,000
Q2 2024

Aug 14, 2024

BUY
$15.08 - $21.23 $417,519 - $587,795
27,687 Added 111.4%
52,541 $946,000
Q1 2024

May 15, 2024

BUY
$9.25 - $19.97 $122,507 - $264,482
13,244 Added 114.07%
24,854 $453,000
Q4 2023

Feb 14, 2024

BUY
$5.51 - $12.1 $63,971 - $140,481
11,610 New
11,610 $127,000
Q1 2022

May 16, 2022

SELL
$9.1 - $18.97 $110,992 - $231,377
-12,197 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$14.41 - $22.41 $175,758 - $273,334
12,197 New
12,197 $186,000
Q2 2021

Aug 16, 2021

SELL
$21.33 - $30.25 $430,546 - $610,596
-20,185 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$30.0 - $35.99 $605,550 - $726,458
20,185 New
20,185 $656,000

Others Institutions Holding EWTX

About Edgewise Therapeutics, Inc.


  • Ticker EWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 63,171,700
  • Market Cap $2.02B
  • Description
  • Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...
More about EWTX
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.